Citadel Advisors’s Apollomics APLM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$224K Buy
+10,664
New +$161K ﹤0.01% 11806
2024
Q4
Sell
-5,429
Closed -$77.2K 14450
2024
Q3
$77.2K Buy
5,429
+4,283
+374% +$68.6K ﹤0.01% 11453
2024
Q2
$23.8K Buy
+1,146
New +$42.8K ﹤0.01% 12485
2024
Q1
Sell
-547
Closed -$52.8K 14506
2023
Q4
$52.8K Buy
+547
New +$67.3K ﹤0.01% 11728

Other funds holding APLM

Citadel Advisors's APLM Position: Q2 2026 in Review

Citadel Advisors opened a new position in Apollomics (APLM) in Q2 2026: 10,664 shares worth $224K. The stake represents ﹤0.01% of the portfolio and ranks #11806 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in APLM as recently as Q3 2024.

Citadel Advisors first reported a position in APLM in Q4 2023 and has held it in 4 quarters since. 4 funds tracked by Wall St. Rank hold APLM as of Q2 2026.

  • Citadel Advisors held 10,664 shares of Apollomics worth $224K as of Q2 2026.
  • Apollomics was a new Citadel Advisors position in Q2 2026.
  • Apollomics made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #11806 holding.
  • Citadel Advisors first reported a position in Apollomics in Q4 2023 and has held it in 4 quarters since.
  • 4 funds tracked by Wall St. Rank held Apollomics as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.